Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Sommer, M; Singer, C; Werkl, P; Seidel, G.
Intermediate uveitis
SPEKTRUM AUGENHEILKD. 2024; Doi: 10.1007/s00717-023-00565-w
Web of Science FullText FullText_MUG

 

Leading authors Med Uni Graz
Seidel Gerald
Sommer Michael
Co-authors Med Uni Graz
Singer Christoph
Werkl Peter Johannes
Altmetrics:

Dimensions Citations:
Plum Analytics:


Scite (citation analytics):

Abstract:
Intermediate uveitis is an inflammation that primarily affects the vitreous, but it might include additional inflammation of the retinal vasculature. Patients tend to be younger, although all age groups can be affected. Approximately 20% of uveitis cases in tertiary referral centers are intermediate uveitis. Most cases are idiopathic (60%), and only 1% are infectious. Overall, 11% of cases are associated with multiple sclerosis and 8% with sarcoidosis. Therapy includes steroids (systemic, parabulbar, intraocular) as first-line treatment, but due to the frequently persistent inflammation, steroid-sparing immunosuppression is frequently needed. Despite the often chronic course of intermediate uveitis, the prognosis is relatively good.

Find related publications in this database (Keywords)
Pars plantitis
Overlap syndrome
Sarcoidosis
Multiple sclerosis
Vitritis
© Med Uni GrazImprint